Key Details
Annual ROE
333.04%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Nov 08, 2021Recent annual earnings:
Mar 01, 2021Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Jan 18, 2023Analyst ratings
Recent major analysts updates
No data about analysts updates
Screeners with IDRA included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Idera Pharmaceuticals doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
Energy Recovery Wins “Breakthrough Innovation Award” at IDRA World Congress
IDRA
businesswire.com16 December 2024
ABU DHABI, United Arab Emirates--(BUSINESS WIRE)--At the 2024 IDRA World Congress show this week, Energy Recovery, Inc. (Nasdaq: ERII) was honored with The Breakthrough Innovation Award for Most Innovative Company in Desalination Technology. The award, announced at the IDRA World Congress Gala Dinner, “recognizes the pioneering efforts and transformative impact of a company, utility, or agency at the forefront of desalination technology.” Energy Recovery has been the trusted gold standard in en.
FAQ
- What is the primary business of Idera Pharmaceuticals?
- What is the ticker symbol for Idera Pharmaceuticals?
- Does Idera Pharmaceuticals pay dividends?
- What sector is Idera Pharmaceuticals in?
- What industry is Idera Pharmaceuticals in?
- What country is Idera Pharmaceuticals based in?
- When did Idera Pharmaceuticals go public?
- Is Idera Pharmaceuticals in the S&P 500?
- Is Idera Pharmaceuticals in the NASDAQ 100?
- Is Idera Pharmaceuticals in the Dow Jones?
- When was Idera Pharmaceuticals's last earnings report?
- When does Idera Pharmaceuticals report earnings?
What is the primary business of Idera Pharmaceuticals?
Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for oncology and rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors, metastatic melanoma, squamous cell carcinoma of the head and neck, and colorectal cancer. The company has a collaboration and supply agreement with AbbVie Inc. and Bristol-Meyers Squibb. Idera Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Exton, Pennsylvania.
What is the ticker symbol for Idera Pharmaceuticals?
The ticker symbol for Idera Pharmaceuticals is NASDAQ:IDRA
Does Idera Pharmaceuticals pay dividends?
No, Idera Pharmaceuticals does not pay dividends
What sector is Idera Pharmaceuticals in?
Idera Pharmaceuticals is in the Healthcare sector
What industry is Idera Pharmaceuticals in?
Idera Pharmaceuticals is in the Biotechnology industry
What country is Idera Pharmaceuticals based in?
Idera Pharmaceuticals is headquartered in United States
When did Idera Pharmaceuticals go public?
Idera Pharmaceuticals's initial public offering (IPO) was on 25 January 1996
Is Idera Pharmaceuticals in the S&P 500?
No, Idera Pharmaceuticals is not included in the S&P 500 index
Is Idera Pharmaceuticals in the NASDAQ 100?
No, Idera Pharmaceuticals is not included in the NASDAQ 100 index
Is Idera Pharmaceuticals in the Dow Jones?
No, Idera Pharmaceuticals is not included in the Dow Jones index
When was Idera Pharmaceuticals's last earnings report?
Idera Pharmaceuticals's most recent earnings report was on 8 November 2021
When does Idera Pharmaceuticals report earnings?
The date for Idera Pharmaceuticals's next earnings report has not been announced yet